Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 15621 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; P41 BTRC review 

(2015/05). 

Date: May 27, 2015. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, Suite 920, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Manana Sukhareva, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

6707 Democracy Boulevard, Suite 959, 

Bethesda, MD 20892, (301) 451–3397, 

sukharem@mail.nih.gov. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; 2015–10 SBIR HD 

Review. 

Date: June 24, 2015. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, Suite 920, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Ruth Grossman, DDS, 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institute of Health, 6707 Democracy 

Boulevard, Rm. 960, Bethesda, MD 20892, 

(301) 496–8775, grossmanrs@mail.nih.gov. 

Dated: March 19, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06698 Filed 3–23–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women (ACBCYW) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 1:00 p.m.–4:00 p.m. 

EST, April 17, 2015. 

Place: This meeting is accessible by 

teleconference and web access. 

Teleconference and web access login 

information is as follows: 

Toll-Free Telephone: 1–800–369– 

1856, Participant passcode: 1927394. 

Net Conference and Web URL: 

For Participants: 

URL: https://www.mymeetings.com/ 

nc/join/. 

Conference number: PW1978421, 

Audience passcode: 1927394 and: 

https://www.mymeetings.com/nc/ 

join.php?i=PW1978421&p=1927394

&t=c. 

Status: Open to the public, limited 

only by the net conference and audio 

phone lines available. 

Purpose: The committee provides 

advice and guidance to the Secretary, 

HHS; the Assistant Secretary for Health; 

and the Director, CDC, regarding the 

formative research, development, 

implementation and evaluation of 

evidence-based activities designed to 

prevent breast cancer (particularly 

among those at heightened risk) and 

promote the early detection and support 

of young women who develop the 

disease. The advice provided by the 

Committee will assist in ensuring 

scientific quality, timeliness, utility, and 

dissemination of credible appropriate 

messages and resource materials. 

Matters For Discussion: The agenda 

will include discussions on the current 

and emerging topics related to breast 

cancer in young women. These may 

include risk communication and health 

education, as well as approaches to 

increase awareness of clinicians/ 

practitioners regarding topics such as 

breast cancer risk, breast health, 

symptoms, diagnosis, and treatment of 

breast cancer in young women. 

Discussions for formal 

recommendations will take place. 

Agenda items are subject to change as 

priorities dictate. 

Online Registration Required: All 

ACBCYW Meeting participants must 

register for the meeting online at least 3 

business days in advance at http:// 

www.cdc.gov/cancer/breast/what_cdc_is

_doing/meetings.htm. Please complete 

all the required fields before submitting 

your registration and submit no later 

than April 14, 2015. 

Contact Person For More Information: 

Temeika L. Fairley, Ph.D., Designated 

Federal Officer, National Center for 

Chronic Disease Prevention and Health 

Promotion, CDC, 4770 Buford Highway 

NE., Mailstop K52, Atlanta, Georgia, 

30341, Telephone (770) 488–4518, Fax 

(770) 488–4760 Email: acbcyw@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06644 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Clinical Laboratory Improvement 

Advisory Committee 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting. 

Times and Dates: 

12:30 p.m.–5:00 p.m., April 15, 2014 

8:30 a.m.–12:00 p.m., April 16, 2014 

Place: CDC, 1600 Clifton Road NE., 

Tom Harkin Global Communications 

Center, Building 19, Auditorium B, 

Atlanta, Georgia 30333. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 100 

people. This meeting will also be 

Webcast, please see information below. 

Purpose: This Committee is charged 

with providing scientific and technical 

advice and guidance to the Secretary of 

Health and Human Services (HHS); the 

Assistant Secretary for Health; the 

Director, Centers for Disease Control 

and Prevention; the Commissioner, 

Food and Drug Administration (FDA); 

and the Administrator, Centers for 

Medicare and Medicaid Services (CMS). 

The advice and guidance pertain to 

mstockstill on DSK4VPTVN1PROD with NOTICES